CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 30 enrolled
Drug / intervention
Fexofenadine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01172522
NCT01172522Phase 2Completed

A Pilot Randomized Double Blind Study to Assess the Safety and Efficacy of 1% Ibuprofen/ 1%Fexofenadine Topical Cream for the Treatment of Dark Circles Under the Eyes

The Connecticut Sinus Center, PC·interventional·Posted Jul 29, 2010·Updated Feb 19, 2015

In Brief

A Phase 2 clinical trial evaluating Fexofenadine and Placebo for Edema. Completed, enrolled 30 participants across 1 site.

Detailed Summary

This study examines topical treatment of under eye circles and swelling.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEdema
CountriesUnited States
CollaboratorsTKL Research, Inc.

Timeline

Phase 2CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedJul 29, 2010
Enrollment StartSep 1, 2010
Primary CompletionDec 1, 2010
Study CompletionJan 1, 2011
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 15.9 years ago

Interventions

Fexofenadinedrug

Fexofenadine 1%

Placebodrug

Placebo